cvs caremark tirzepatide expands coverage options for GLP-1s CVS Caremark Pushes Zepbound Patients

Retrieved June 11, 2025, from Swiss Medica

Dusi, V., Ghidoni, A., Ravera, A., De Ferrari, G

Non-GLP therapies may be considered for patients who: Are not candidates for GLP-1 medications Prefer non-injectable treatment options Have experienced side effects with other therapies Are seeking medically supervised weight management support A licensed clinician will determine the most appropriate treatment approach based on medical history, current conditions, and overall health goals

If you are taking Sublingual Semaglutide for the first time, you will be instructed to begin with a titration as directed by your provider